Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › TLR7 agonist and pharmaceutical combination thereof for treating lung cancer

TLR7 agonist and pharmaceutical combination thereof for treating lung cancer

US Patent 12128047 · Granted Oct 29, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combined pharmaceutical composition for treating tumor2025
Recombinant Escherichia coli for producing glutarate, construction method and us2025
Therapeutic combination of quinoline derivative and antibody2025
Trifluoromethyl-substituted sulfonamide as BCL-2-selective inhibitor2025
Trifluoromethyl-substituted sulfonamide as BCL-2-selective inhibitor2025
Trifluoromethyl-substituted sulfonamide as BCL-2-selective inhibitor2025
Crystals of quinolone derivatives2025
Drug combination containing TLR7 agonist2025
Drug combination containing TLR7 agonist2025
Drug combination containing TLR7 agonist2025
Drug combination containing TLR7 agonist2025
Methyl- and trifluoromethyl-containing disubstituted sulfonamide selective BCL-22025